About Nucleus Network
Nucleus Network is a Healthcare company based in Saint Paul (United States) founded in 2003, and was acquired by Blackstone in November 2021. Clinical trial services are provided for medical research and development. Nucleus Network has completed 1 acquisition, including HMR London. Its website nucleusnetwork.com draws about 236 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Elligo, Acurian and CenExel; 2 of its 3 listed competitors have raised funding.
Company details
Nucleus Network was established in 2003 and is headquartered in Saint Paul, United States. Clinical trial services are offered within the healthcare sector, focusing on patient recruitment, trial management, and data collection. Operations are centered in the U.S., supporting pharmaceutical and biotech firms through early-phase studies. Services include protocol development and regulatory compliance, ensuring efficient trial execution across various therapeutic areas.
- Headquarters Saint Paul, United States
- Stage Acquired
- SectorsHealthcare
- Website category Law and Government · Government
- Website nucleusnetwork.com
- Social LinkedIn
- Acquired by Blackstone (Nov 2021)
- InvestorsBlackstone
& 1 more
- Investments & Acquisitions
- Acquired by
Investors in Nucleus Network
Nucleus Network has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Blackstone and Crescent Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified investment management is provided across multiple asset classes. | 1985 | blackstone.com | New York, United States | |
Crescent Capital Partners is engaged in private equity and asset management. | 2000 | crescentcap.com.au | Sydney, Australia |
Investor details for Nucleus Network
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nucleus Network
9 people are tracked at Nucleus Network (9 in leadership).
| Name | Role | Group |
|---|---|---|
Chris Hickey | Chief Business Development Officer | Leadership |
Teena Pisarev | Chief Executive Officer | Leadership |
Biljana Georgievska | Chief Commercial Officer | Leadership |
Daniel Biase - Mcinally | Chief Financial Officer | Leadership |
Clare Neal | Executive Vice President — People And Culture | Leadership |
Karan Jaiswal | Vice President — Marketing And Customer Experience | Leadership |
Gary Urban | Vice President — Quality | Leadership |
Jason Lickliter | Chief Medical Officer | Leadership |
Graham Wood | Executive Vice President — USA | Leadership |
Complete people profiles for Nucleus Network
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nucleus Network
Nucleus Network has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include HMR London.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CRO which has worked in 670+ trials and specializes in early stage clinical trials | hmrlondon.com | London, United Kingdom | 1993 | Aug 2025 | •••• |
Complete acquisition details for Nucleus Network
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Nucleus Network
4 dated milestones of Nucleus Network across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Nucleus Network is founded.
- Exit Acquired by Crescent Capital Partners.
- Exit Acquired by Blackstone.
- Acquisition Acquires HMR London.
Competitors of Nucleus Network
Nucleus Network has 3 listed competitors in our database, 2 of them funded. They include Elligo, Acurian and CenExel.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| elligohealthresearch.com | 2016 | Austin, United States | $176.48M | 280 | Patient recruitment and site activation services are provided by Elligo. | |
| acurian.com | 1998 | Horsham, United States | $27M | Patient enrollment and retention solutions for clinical trials are offered. | ||
| cenexelresearch.com | 2019 | Salt Lake, United States | 451 | Research site management and patient recruitment services are provided. |
Detailed competitors of Nucleus Network
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nucleus Network
The website of Nucleus Network (nucleusnetwork.com) receives about 236.3K visits a month and ranks #213,417 among all websites worldwide, #7,069 in Government.
- Monthly visits236.3K
▲ 46.7% vs previous month
- Unique visitors72.6K
per month
- Global rank#213,417
among all websites
- Category rank#7,069
Law and Government · Government
- Bounce rate44%
- Pages per visit4.1
- Average visit5 min 53 sec
- DevicesDesktop 24% · Mobile 76%
Websites whose visitors overlap most with Nucleus Network. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dss.gov.au | 100% | #99,030 | View details | ||
my.gov.au | my.gov.au | 97% | #1,330 | – | |
| cmax.com.au | 32% | 62.9K | #476,429 | View details | |
momentumclinicalresearch.com.au | momentumclinicalresearch.com.au | 30% | #1,089,398 | – | |
| paratusclinical.com | 29% | 12.7K | #1,515,022 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Nucleus Network
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Nucleus Network (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nucleus Network
Complete news archive for Nucleus Network
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nucleus Network
Nucleus Network was founded in 2003.
Nucleus Network is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Nucleus Network was established in 2003 and is headquartered in Saint Paul, United States. Clinical trial services are offered within the healthcare sector, focusing on patient recruitment, trial management, and data collection. Operations are centered in the U.S., supporting pharmaceutical and biotech firms through early-phase studies. Services include protocol development and regulatory compliance, ensuring efficient trial execution across various therapeutic areas.
Nucleus Network has made 1 acquisition, including HMR London.
Nucleus Network has 2 investors. Key investors include Blackstone, and Crescent Capital Partners.
Yes. Nucleus Network was acquired by Blackstone in November 2021.
The website of Nucleus Network receives about 236 thousand visits a month and ranks #213,417 among all websites worldwide.